Therefore, based on these studies, it is suggested that reduced activation of TRP family channels, especially TRPA1, TRPV1 and TRPV4, may be potential targets for new therapies for asthma (Dietrich, 2019; Reese et al., 2020). The gene discussed is TRPV1; the disease is asthma.